Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Prevention of opioid-induced constipation in patients with advanced cancer. Recruiting

2023-509462-38-00 Patients with advanced cancer. 11 2022-10-25
Phase 1 dose-escalation trial of OMTX705, an anti-fibroblast activation protein antibody-drug conjugate, as single agent and in combination … Recruiting

2024-514746-36-00 Selected tumor indications that are known to express FA 1 2022-10-20
Clinical trial of infusion of activated NK cells for the treatment of children, adolescents and young adults with sarcomas. Recruiting

2024-513431-25-00 Sarcomas 7 2022-10-18
HOVON 161: A phase II non-inferiority study comparing point-of-care produced CAR T-cell to commercial CAR T-cells in patients with relapsed/… Recruiting

2024-511979-15-00 relapsed/refractory Non-Hodgkin Lymphoma 4 2022-10-14
CAPTOR-BC: COMPREHENSIVE ANALYSIS OF SPATIAL, TEMPORAL AND MOLECULAR PATTERNS OF RIBOCICLIB EFFICACY AND RESISTANCE IN ADVANCED BREAST CANCE… Recruiting

2022-500764-35-00 Patients with advanced HER2-negative, hormone receptor 6 2022-10-13
Cholangiocarcinoma treatment with radiofrequency ablation or photodynamic therapy Recruiting

2022-500107-50-00 hilar cholangiocarcinoma 6 2022-10-12
Study of AZD9574 as monotherapy and in combination with anti-cancer agents in patients with advanced solid malignancies Recruiting

2023-504984-17-00 Module 3: advanced/relapsed HER2-negative breast, ovari 7 2022-10-05
DK-CLIC-1901 CAR T-cells for treatment of patients with relapsed/refractory CD19 positive hematological malignancies (DAN-CART 1901) Recruiting

2024-515174-27-00 Acute Lymphoblastic Leukemia and B-cell Non Hodgkin Lym 4 2022-10-03
Study to determine the dose and safety of asciminib in pediatric patients with chronic myeloid leukemia. Recruiting

2023-508129-28-00 Pediatric patients with Philadelphia chromosome positiv 9 2022-09-28
SPRING Rollover Recruiting

2022-500041-24-00 Lung cancer (non-small cell lung cancer) 9 2022-09-27
Prospective randomized multicenter phase III trial of decitabine and venetoclax administered in combination with all-trans retinoic acid or … Recruiting

2023-507461-26-00 Newly diagnosed acute myeloid leukemia (AML) 5 2022-09-22
Phase II Dutasteride in combination with CAB vs CAB in SDC (DUCT) Recruiting

2022-500745-24-00 Salivary Duct Carcinoma 10 2022-09-20
A phase I trial evaluating the safety, tolerability, and pharmacokinetic profile of INP12 in patients with advanced solid tumors. Recruiting

2024-518126-32-00 Patients with advanced solid tumors. 1 2022-09-15
CPX-351 versus intensive chemotherapy in patients with de novo intermediate or adverse risk AML stratified by genomics Recruiting

2022-500295-60-00 Acute Myeloid Leukemia 4 2022-09-15
MetroWilms Recruiting

2022-502687-20-00 Wilms tumor 4 2022-09-14
Long-term Follow-up Study for Participants Previously Treated with Ciltacabtagene Autoleucel Recruiting

2023-505530-10-00 Multiple Myeloma 6 2022-09-14
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone versus Lenalidomide Alone in Participants With Newly Dia… Recruiting

2023-510384-36-00 Newly Diagnosed Multiple Myeloma 5 2022-09-13
A Phase 1b/2, Open-Label Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants with Advanced or … Recruiting

2023-506517-22-00 Advanced or Metastatic Colorectal Cancer 9 2022-08-31
Asciminib Roll-over Study Recruiting

2023-507557-16-00 chronic myelogenous leukemia (CML) or Philadelphia Chro 5 2022-08-31
A Phase 3 Study Comparing Pirtobrutinib to Ibrutinib in CLL/SLL Recruiting

2023-507699-38-00 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 5 2022-08-30
Use of Imatinib to convert triple negative breast cancer into ER-positive breast cancer - I-CONIC Recruiting

2024-511141-19-00 Primary breast cancer 4 2022-08-22
Immunological variables associated to ICI toxicity in cancer patients Recruiting

2023-505360-11-00 solid tumour 4 2022-08-18
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple M… Recruiting

2023-506247-42-00 Relapsed/Refractory Multiple Myeloma 3 2022-08-17
A Phase 1, Open-Label, Multicenter Study of INCB123667 as Monotherapy and in Combination With Anticancer Therapies in Participants With Sele… Recruiting

2024-512822-28-00 Advanced or metastatic solid tumors 1 2022-08-08